GSK’s cobolimab has become the latest anti-TIM-3 antibody to flunk a crucial oncology test, as the pharma absorbs a more than $600 million hit from its anti-TIGIT drug failure. | GSK’s cobolimab has ...

The miner reported a 22% fall in first-half profit and pared its interim dividend. Sales grew 9% at constant exchange rates despite continued soft demand for luxuries that is taking a toll on most of ...

LONDON (AP) — LONDON (AP) — GSK plc (GSK) on Wednesday reported second-quarter earnings of $1.93 billion. The London-based company said it had profit of 94 cents per share. Earnings, adjusted for ...

GSK Plc reported better-than-expected profit and raised its estimates for revenue at two key divisions in a report that ...

British drugmaker GSK said on Wednesday it is in talks with the Trump administration about ways to lower U.S. drug costs, ...

British pharmaceutical company GlaxoSmithKline on Wednesday said its annual performance should be better than expected, despite US tariffs, after sales of its cancer drugs jumped in the second quarter ...

Revenue in the second quarter of 2025 rose 1.3% to GBP7.99 billion from GBP7.88 billion, helping to push pretax profit up 26% to GBP1.89 billion from GBP1.50 billion. Core operating profit rose 12% at ...

GSK said it is confident of achieving the top end of its full-year guidance after posting an increase in sales and profit for the second quarter, mainly driven by the strong performance of its ...

GSK said on Wednesday it expects to report annual sales and profit towards the top end of its forecast range, after the ...

Actuate Therapeutics' elraglusib shows promise in metastatic pancreatic cancer. Upcoming FDA meeting may accelerate approval.

Sparrow raises $35M Series B to scale AI-powered employee leave management platform that has grown 14x since 2021, serving ...